Abstract
Recently, Streptococcus suis reference strains of serotype 20, 22, and 26 were reclassified as Streptococcus parasuis. The public health significance of S. parasuis is underestimated due to the lack of clinical isolates. In the present study, we first reported two sporadic S. parasuis infections in humans, after using full-length 16S rRNA and housekeeping genes’ phylogeny and ANI values of genome sequence comparisons to determine the species of their isolates BS26 and BS27. Compared to highly pathogenic S. suis strain P1/7, S. parasuis strains BS26 and BS27 possessed a delayed capacity to initiate lethal infection, which may attribute to the later production of higher level of pro-inflammatory cytokines. Differed to S. suis strain P1/7, S. parasuis strains did not induce significant inflammatory response in the brain of mice. Histopathological changes in liver and lungs were widely present in mice infected with S. parasuis strains. Our data indicated that the pathogenic mechanism of S. parasuis may be different from that of S. suis. Three lineages in the core-genome phylogenetic tree and ten types of cps gene cluster were found in 13 S. parasuis genomes, indicating high heterogeneity of this species. The similarity of CPS structure and antibiotic-resistant genes relative to S. suis indicated the evolutionary affinity between the two species. Our data suggested S. parasuis is a potential zoonotic pathogen and poses severe threat to health of susceptible people. Further study on the epidemiology and public health significance of S. parasuis is urgently necessary.
Keywords: S. parasuis, human infection, virulence, histopathologic changes, pro-inflammatory cytokines, antimicrobial resistance, phylogeny, cps
1. Introduction
Streptococcus suis is an important zoonotic pathogen that causes primarily meningitis, sepsis, endocarditis, arthritis, and pneumonia in both pigs and humans [1,2]. Currently, 35 serotypes (types 1 through 34 and 1/2) of S. suis have been identified on the basis of their capsular polysaccharide antigens (CPS) [1,3]. S. suis serotypes 32 and 34 have been reclassified as Streptococcus orisratti [4]. Recently, S. suis reference strains of serotypes 20, 22, 26 were proposed as Streptococcus parasuis [5] and serotype 33 was reclassified as Streptococcus ruminantium [6]. The presence of S. parasuis in diseased pigs and calves with pneumonia or systemic infection (meningitis, arthritis, endocarditis, or septicemia) indicated that S. parasuis may be pathogenic to pigs and/or calves [7,8,9,10]. The public health significance of S. parasuis has not been evaluated thoroughly, due to the lack of clinical isolates and published case reports. Strains BS26 and BS27 isolated from two patients and reported in the current study were classified as S. parasuis species by combining full-length 16S rRNA and housekeeping genes’ phylogeny and ANI values of genome sequence comparisons. To evaluate the potential virulence of BS26 and BS27, the survival curve, histopathological lesions, and kinetics of inducing pro-inflammatory cytokines production in vivo were compared to those of highly pathogenic S. suis strain P1/7 [11]. Additional 11 genomes of S. parasuis available in NCBI were included to investigate the phylogeny and genomic features of S. parasuis.
2. Results
2.1. Phylogenetic Analysis of Full-Length 16S rRNA and Housekeeping Genes groEL, gyrB, sodA, and recN of S. parasuis
Strain BS27 had 16S rRNA gene sequence similarity with BS26 equal to 100%. Phylogenetic analysis using 16S rRNA gene sequences demonstrated that strains BS26 and BS27 were 98.9% similar to S. parasuis type strain SUT-286T but 96.6% similar to S. suis type strain NCTC10234T (Table S1). A dendrogram was constructed from a similarity matrix using the 16S rRNA sequences from 16 S. parasuis strains (the full-length 16S rRNA gene sequences were not extracted from draft genomes SUT-319 and SUT-380), S. suis type strain NCTC10234T, and E. faecalis JCM 5803 (Figure 1). S. suis type strain NCTC10234T and E. faecalis JCM 5803 were distant from S. parasuis strains that fell into a group. Compared with other 14 S. parasuis strains, the similarity of 16S rRNA sequences of BS26 and BS27 ranged from 98.9% to 99.6% (Table S1). The similarity of 16S rRNA sequences among 16 S. parasuis ranged from 98.8% to 100%. The similarity of 16S rRNA sequences between S. parasuis and S. suis ranged from 96.5% to 97.6%. (Table S1).
In addition to the 16S rRNA gene, housekeeping genes such as groEL, gyrB, sodA, and recN were also suitable and helpful for Streptococcus strain differentiation at the species level [12,13]. Strain BS27 shared 100% housekeeping-gene sequence similarity with BS26. Sequence analysis of housekeeping genes groEL, gyrB, sodA, and recN demonstrated that strains BS26 and BS27 were 97.6%, 97.6%, 97.4%, and 98.7% similar to S. parasuis type strain SUT-286T, respectively (Table S1). Consistent with the 16S rRNA gene result, S. parasuis strains were grouped together and were well separated from S. suis NCTC10234T in the phylogenetic trees that were based on the groEL, gyrB, sodA, and recN genes (Figure 1). Divergence values of 0–5.8%, 0–2.8%, 0–2.7%, and 0–3.1% among S. parasuis strains were obviously lower than 7–8.5%, 15.7–16.3%, 23–25%, and 15.3–17% with S. suis strain NCTC10234T for the groEL, gyrB, sodA, and recN genes, respectively (Table S1).
Strains BS26 and BS27 had an average nucleotide identity (ANI) value of 95.1% and 95.2% with S. parasuis type strain SUT-286T, respectively (Table S1). In contrast to the high similarity with S. parasuis type strain SUT-286T, ANI values of BS26 and BS27 were 83.42% and 83.33% with S. suis type strain NCTC10234T, respectively. ANI values among 13 genomes of S. parasuis were in the range 93.8–99.99%, obviously higher than the range 83.33–84.72% with S. suis type strain NCTC10234T (Table S1).
2.2. Difference in Virulence between S. suis Strain P1/7 and Two S. parasuis Strains
In order to evaluate the potential virulence of S. parasuis BS26 and BS27, we compared the survival curve of C57BL/6 mice infected with two S. parasuis strains and highly pathogenic S. suis strain P1/7. Most mice infected with P1/7, BS26 or BS27 showed severe septic signs in period of the infection, such as rough hair coat, swollen eyes, weakness, and shivering.
The survival rate of mice infected with S. suis strain P1/7 or two S. parasuis strains was significantly different from that of mock-infected mice. Moreover, significant difference in the survival level was also observed between mice infected with S. suis strain P1/7 and two S. parasuis strains, which attributed to the differences at an early phase of the infection. Mice infected with S. suis strain P1/7 had a 20% survival rate at 8 h post-infection, while mice infected with S. parasuis strain BS26 and BS27 had a 95% and 90% survival rate at the same time point, respectively. It is noteworthy that the survival levels of mice infected with BS26 and BS27 dramatically decreased after 12 h post-infection. At 24 h post- infection, survival rates of the P1/7-infected group (15%), BS26-infected group (20%), and BS27-infected group (25%) were very similar (Figure 2 and Table S2).
2.3. Histopathological Lesions and Bacterial Load in Survival Mice
Totally, three mice infected with S. suis strain P1/7, three mice infected with S. parasuis strain BS26, and five mice infected with S. parasuis strain BS27 survived at 72 h post-infection in survival experiment. Strains were isolated in the peripheral blood, brain, lung, liver, spleen, and kidney of all survival mice.
Slight deformation of neuron was found in the brains of seven mice infected with S. parasuis strain (Figure 3A(1)). Only one mouse infected with S. parasuis BS26 was observed slightly infiltrated by lymphocytes (Figure 3A(1)). Histopathological lesions of S. parasuis-infected mice were mainly observed in the lung and liver. These organs presented bacterial loads over 102 CFU/0.1 g. Hepatocyte steatosis was significant histopathological changes of livers and was present in all S. parasuis-infected mice (Figure 3B(1)). Coagulative necrosis was observed in the liver of two mice infected with the S. parasuis strain (Figure 3B(1)). Alveoli wall thickening with diffused infiltration of neutrophils and lymphocytes was observed in the lung of all S. parasuis-infected mice (Figure 3C(1)). Some hemorrhagic foci in lungs were also found in the two mice infected with S. parasuis strain (Figure 3C(2)). No significantly histopathological changes were observed in the heart and spleen of S. parasuis-infected mice.
Different from S. parasuis strains-infected mice, neuronal necrolysis and significant infiltration by neutrophils were observed in brains of all mice infected with S. suis strain P1/7 (Figure 3A(2)). Although bacterial loads ranged from 102 to 104 CFU/0.1 g in other organs of mice infected with S. suis strain P1/7, no significantly histopathological lesions were observed in them (Figure 3B(2),C(3)). Bacterial counts of mice infected with S. suis were significantly higher than those of mice infected with S. parasuis, except for the liver (Figure 3D).
2.4. Pro-Inflammatory Cytokine Production and Bacterial Loads in Mice Infected with S. parasuis Strain BS26 and S. parasuis Strain P1/7
Proinflammatory cytokines were responsible for the death of mice infected with S. suis strains within 24 h post infection [14,15,16]. The kinetics of proinflammatory cytokines induced by P1/7 and BS26 within 24 h post-infection was compared. Stimulations with S. parasuis strain BS26 and S. suis strain P1/7 induced time-dependent production of IL-6 and TNF-a in mice. The kinetics and levels of IL-6 and TNF-a that were induced in vivo were different between the two strains. S. suis strain P1/7 was able to induce significantly more rapid production and higher levels of IL-6 and TNF-a early in the post-infection period, reaching peaks of 54,027 pg/mL and 2067 pg/mL at 8 h, respectively. Then, levels of cytokines gradually decreased from 12 h to 24 h post-infection. The pattern of TNF-a induced by BS26 in vivo was similar to those patterns of cytokines induced by P1/7, peaking at 8 h post-infection and gradually decreasing thereafter. In contrast, the level of IL-6 induced in vivo by BS26 peaked at 34,690 pg/mL at 12 h post-infection and gradually decreased thereafter. Moreover, BS26 induced higher levels of IL-6 than P1/7 did at 12 h post-infection. Significantly higher levels of cytokines were produced by S. suis strain P1/7 at 4, 8, 16, and 24 h post-infection than those produced by S. parasuis strain BS26 (Figure 4A,B).
In the present study, we also counted the bacterial loads in the peripheral blood, liver, lung, and brain of infected mice at 4, 8, 12, 16, and 24 h post-infection. The bacterial counts in the peripheral blood and organs of mice infected with S. suis strain P1/7 were statistically higher than those of S. parasuis strain BS26-infected mice.
In S. parasuis strain BS26-infected group, bacterial counts in the peripheral blood reached 106 CFU/mL at 4 h post-infection; and then descended dramatically to 104 CFU/mL at 8 and 12 h post-infection, and 102 CFU/mL at 24 h post-infection (Figure 4C). Viable counts in the brain presented similar kinetics, peaked at 104 CFU/0.1 g at 4 h post-infection and gradually decreased to 103 CFU/0.1 g at 24 h post-infection (Figure 4D). In contrast, bacterial counts in the liver and lung showed a different pattern. Viable counts in the liver and lung reached approximately 106 CFU/mL at 4 h post-infection, peaked over 106 CFU/0.1 g at 12 h post-infection and gradually decreased to 105 CFU/0.1 g at 24 h post-infection (Figure 4E,F). It is noteworthy that bacterial counts in the liver and lung were higher than that of peripheral blood from 8 h to 24 h post-infection.
In S. suis strain P1/7-infected group, bacterial counts in the peripheral blood reached 108 CFU/mL at 4 h post-infection, remained at 108 CFU/mL at 8 and 12 h post-infection, and slightly decreased to 106 CFU/mL at 24 h post-infection (Figure 4C). Kinetics of viable counts in the organs were similar to those of mice infected with S. parasuis strain BS26. Viable counts in the brain peaked at 108 CFU/mL at 4 h post-infection and gradually decreased to 106 CFU/mL at 24 h post-infection (Figure 4D). Viable counts in the liver and lung reached 106 CFU/0.1 g at 4 h post-infection, peaked at 107 CFU/0.1 g at 12 h post-infection, and slightly decreased to 106 CFU/0.1 g at 24 h post-infection (Figure 4E,F).
2.5. AR Genes and Antimicrobial Susceptibility Profiles of BS26 and BS27
Only msr(D) and mef(A) genes that code for resistance to macrolides were found in genomes of BS26 and BS27. Lower levels of resistance to erythromycin and azithromycin was found in S. parasuis strains BS26 and BS27, and those levels were attributed to msr(D) and mef(A) genes with MICs 8 and 24 μg/mL, respectively. It is noteworthy that S. parasuis strains BS26 and BS27 were resistant to trimethoprim–sulfamethoxazole with an MIC > 32 μg/mL, although they did not harbor AR genes that were known to be related. In addition, S. parasuis strain BS26 and BS27 were susceptible to penicillin G, cefaclor, clindamycin, vancomycin, chloramphenicol, tetracycline, streptomycin, kanamycin, spectinomycin, and gentamicin.
2.6. Comparative Genomic Analysis of S. parasuis
The core-genome phylogenetic tree based on 442 core genes of 14 Streptococcus genomes indicated great diversity among S. parasuis genomes, which were clustered into three discrete lineages (Figure 5). Lineage 1 contained BS26, BS27, and four additional public genomes. Lineage 2 contained the reference genomes of serotype 20, 22, and 26, type strain SUT-286T, and two additional public genomes. Lineage 3 only contained SUT-7, which was distant from other S. parasuis genomes.
2.7. The Analysis of Cps Gene Clusters of S. parasuis
Complete cps gene clusters were extracted from eleven of 13 S. parasuis genomes. The three sides of cps gene clusters was deleted in genomes SUT-286T and 4253. The cps gene cluster of BS26 was identical to that of BS27. The cps gene clusters of S. parasuis were located between the CDS1210 and CDS1209 genes (named as homologous genes in S. suis genome P1/7) and belonged to pattern III, identical to that of reference strains of serotype 20, 22, and 26 [17]. The fact that all cps gene clusters of S. parasuis harbored wzy/wzx genes indicated that CPs of S. parasuis were synthesized by the WZX/WZY pathway. The conserved cpsA, cpsB, cpsC, and cpsD were present and located on the 5′ side of the cps gene clusters. The central regions of these clusters were highly variable. The cps gene clusters were clustered into ten types (I to X) based on the sequence of the wzy gene (Table 1). Among them, cps types VI and X contained three genomes (SUT-319, SUT-328, and SUT-380) and two genomes (BS26 and BS27), respectively. Other cps types comprised one genome each. The wzy genes of type V, VII, IX, and X were highly homologous to those of S. thermophilus EPS type VI, S. suis serotype 24, S. suis serotype 10, and S. thermophilus EPS type V, respectively (Figure 6).
Table 1.
Strains | Source | Location | Year | cps Type | Accession No. |
---|---|---|---|---|---|
BS26 | Patient | China | 2018 | X | CP069079 |
BS27 | Patient | China | 2018 | X | JAETXU000000000 |
86-5192 | Diseased calf | United States | 1980’ | I | PRJNA171426 |
88-1861 | Diseased pig | Canada | 1980’ | II | PRJNA171444 |
89-4109-1 | Diseased pig | / | 1980’ | III | PRJNA171433 |
SUT-7 | Healthy pig | Japan | / | V | DRX016751 |
SUT-286 | Healthy pig | Japan | / | IV | DRX016752 |
SUT-319 | Healthy pig | Japan | / | VI | DRX016753 |
SUT-328 | Healthy pig | Japan | / | VI | DRX016754 |
SUT-380 | Healthy pig | Japan | / | VI | DRX016755 |
10-36905 | Healthy Bos taurus | United States | 2010 | VII | PRJNA590796 |
2674 | Healthy pig | China | 2014 | VIII | POIG00000000 |
4253 | Healthy cow | Switzerland | 2018 | IX | SHGT00000000 |
3. Discussion
Two strains—BS26 and BS27—were isolated from the blood cultures of two patients and initially identified as S. suis by MALDI-TOF MS. In the present study, the 16S rRNA gene sequence similarity between two strains and S. parasuis type strain SUT-286T exceeded 98.7%, the threshold value to delineate the species [18]. Sequence analysis of their groEL, gyrB, rpoB, sodA, and recN genes also showed that the two strains had phylogenetic affinity with the S. parasuis species.
ANI value can be used as a parameter to determine whether two genomes belong to the same species. The ANI cut-off value for species definition is species-dependent. Average ANI of the same species varies from 0.779 (Polynucleobacter necessaries) to 0.998 (Leptospira biflexa) [19]. By comparison of pairs of 1226 bacterial strains with whole genome sequences, bacterial species definition using cut-off value of 0.92 matched the current bacterial species definition well [19]. In the present study, BS26 and BS27 had ANI values of 95.1% and 95.2% with S. parasuis type strain SUT-286T, respectively. These ANI values are higher than the 95% cut-off ANI value for bacterial species that Goris et al. proposed [20]. It is important that full-length 16S rRNA and housekeeping genes’ and core-genome phylogeny demonstrated that S. suis type strain NCTC10234T formed a distinct branch and was well separated from S. parasuis. By combining full-length 16S rRNA and housekeeping genes’ phylogeny and ANI values of genome sequence comparisons, it is concluded that the BS26 and BS27 strains belonged to the S. parasuis species. Before the present study, S. parasuis had been isolated from healthy and diseased pigs or calves [7,8,9,10]. The present study makes the first report of sporadic S. parasuis infections in humans. It is possible that the prevalence and clinical relevance of S. parasuis have been underestimated because of a lack of effective methods to identify it.
To evaluate the potential virulence of S. parasuis strains BS26 and BS27, the survival curve, histopathological lesions, and kinetics of pro-inflammatory cytokines production in vivo were compared to those of highly pathogenic S. suis strain P1/7. Compared to S. parasuis strain BS26- and BS27-infected mice, those infected with S. suis strain P1/7 quite rapidly succumbed to the infection. Significant differences at the early phase of infection and similarity at the middle phase of infection in survival level were observed between S. suis strain P1/7-infected group and S. parasuis strains-infected groups. The results indicated that S. parasuis strains BS26 and BS27 possessed a delayed capacity to initiate lethal infection.
The histopathological lesions in major organs were also investigated in all survival mice at 72 h post infection of survival assay. Consistent with the results of previous study [15], survival mice infected with S. suis strain P1/7 initiated significant inflammation in brains. Obviously higher bacterial loads present in brains of mice infected with S. suis P1/7 may contribute to the histopathological changes. No significant inflammatory response was found in the brains of the survival mice infected with S. parasuis strains. Histopathological lesions of survival mice infected with S. parasuis were widely present in lungs and livers. Hepatocyte steatosis was present in all S. parasuis infected mice. Hepatic mitochondrial and its enzyme activity may be impaired in response to sepsis induced by S. parasuis, causing hepatic lipid utilization disorder. Significant inflammation in lungs were observed in all survival mice infected with the S. parasuis strain. It is noteworthy that S. parasuis strain BS27 also led to the inflammation of both lungs in its host.
In previous studies, no significant histopathological changes in organs were observed in dead mice infected with S. suis within 48 h post-infection [14,15]. Proinflammatory cytokines played a critical role in the death of mice or patients infected with S. suis within 24 h post-infection [15,16,21]. The overproduction of pro-inflammatory cytokines such as TNF-a and IL-6 plays an important role in the infection caused by S. suis [21]. IL-6 is an important inducer of acute phase proteins [22]. High levels of IL-6 correlate inversely with survival time in patients with sepsis [23]. TNF-α is one of the most important host mediators in the pathogenesis of septic shock [24] and may be responsible for the streptococcal toxic shock-like syndrome (STSLS) observed in the Sichuan outbreak [25]. In order to explicate the difference in mortality between mice infected with S. suis strain P1/7 and S. parasuis strains at early phase of infection, we also compared their kinetics of inducing TNF-a and IL-6 production in vivo within 24 h post-infection. The capacity of S. parasuis strain BS26 to induce TNF-α production in vivo is obviously lower than that of S. suis strain P1/7 during the whole infection. However, S. parasuis BS26 induced higher levels of IL-6 at 12 h post-infection. Interestingly, the survival levels of mice infected with S. parasuis srains dramatically decreased after 12 h post-infection. The later inflammatory response might result in most mice infected with S. parasuis strains succumbed to the infection at middle stage of survival experiment.
It is noteworthy that the bacterial loads of S. parasuis strain BS26 in peripheral blood and major organs were obviously lower than those of S. suis strain P1/7 during the infection. Moreover, S. parasuis strains BS26 and BS27 did not harbor “classical” S. suis virulence markers mrp, sly, and epf (data were not shown). Combined with the result of histopathology, we suspected the pathogenic mechanism of S. parasuis may be different from that of S. suis.
In the present study, both S. parasuis strains carried AR genes msr(D) and mef(A) that are mainly associated with resistance to macrolide. The category and number of AR genes carried by S. parasuis strains BS26 and BS27 were lower than those of S. suis clinical strains [26,27]. The acquisition and dissemination of AR genes in S. suis are strongly associated with mobile genetic elements (MGEs), which are mainly integrative and conjugative elements (ICEs) and prophages [28]. We did not find MGEs in 13 genomes of S. parasuis (data were not shown). Further studies are needed to investigate the formation and dissemination mechanisms of AR genes in S. parasuis population.
In the present study, the phylogeny of 13 S. parasuis genomes were analyzed. The ANI values range from 93.8% to 99.99% indicating obvious heterogeneity among S. parasuis genomes. Consistent with the ANI values, the core-genome phylogeny clustered 13 S. parasuis genomes into three discrete lineages. S. parasuis strains BS26 and BS27 had phylogenic affinity with S. parasuis strain 4253 and were clustered into Lineage 1, which also contained three other genomes: SUT-319, SUT-328, and SUT-380.
In the present study, the genetic characteristics of cps loci in each genome were investigated. As with that of reference strains of serotypes 20, 22, and 26, all complete cps gene clusters of S. parasuis belonged to pattern III [17]. They shared highly conserved cpsA, cpsB, cpsC, and cpsD genes and flanked regions with serotype reference strains of S. suis, indicating the phylogenetic affinity between S. suis and S. parasuis. The possession of wzy/wzx genes in each cps gene cluster strongly suggests that the CPs of all S. parasuis were synthesized using the WZX/WZY pathway. The cps gene clusters were clustered into ten groups on the basis of the sequences of wzy gene. In a previous study, SUT-286T and SUT-380 agglutinated with the antisera of serotypes 20 and 22, respectively, whereas isolates SUT-7, SUT-319, and SUT-328 cross-reacted with antisera 22/26, 20/22, and 20/22, respectively [5]. However, obvious differences in sequences of the central regions including wzx and wzy genes were found among them in the present study. We reasonably speculate that the agglutination reactions were non-specific. Moreover, the central regions including wzx and wzy genes of four cps types of S. parasuis had high similarity with those of S. thermophilus and S. suis, respectively. Previous studies have shown recombination between cps gene clusters of S. suis and S. pneumonia [29,30]. These data indicated that intraspecies horizontal transfer of cps gene clusters among Streptococcus had frequently occurred. The presence of many different types of cps loci in S. parasuis also indicated high heterogeneity of this species.
In conclusion, we first reported the sporadic S. parasuis infections in humans. Two S. parasuis strains isolated in patients possessed a delayed capacity to initiate lethal infection. Our data suggested S. parasuis as a potentially zoonotic pathogen could severely threat to health of susceptible people. Obvious heterogeneity was found among S. parasuis genomes. The similarity of CPS structure and AR genes relative to S. suis indicated the evolutionary affinity between the two species. Further study on the epidemiology and public health significance of S. parasuis is urgently necessary.
4. Materials and Methods
4.1. Bacterial Strains and Case Description
Strains BS26 and BS27 were isolated from blood cultures of peritonitis patient and arthritis patient with pneumonia in 2018, respectively. They were identified as S. suis by matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF, Microflex LRF, Bruker) method with log-score 1.82 and 1.85 (1.700 < score < 1.999 indicates “probable genus identification”), respectively. The two strains were confirmed as not belonging to S. suis by amplifying a nearly complete 16S rRNA gene using primer 27F(5′-AGAGTTTGATCMTGGCTCAG-3″) and 1492R (5′-TACGGYTACCTTGTTACGACTT-3′) and S. suis–specific recN and gdh genes [31,32,33,34]. Data of 16S rRNA sequencing and the PCR method detecting recN gene specific to S. parasuis [6] indicated that the two strains belonged to the S. parasuis species.
On 9 June 2018, a 27-year-old female patient as host of BS26 was admitted to the Affiliated Hospital of Youjiang Medical University for Nationalities in Baise city because of peritonitis characterized by acute onset of fever (body temperature of 38.1 °C) and persistent periumbilical colic. Two years earlier, the patient was diagnosed with renal hypertension. The serum level of high-sensitivity C-reactive protein (hsCRP) (cobas c 702, Roche) measured by nephelometry and total counts of white blood cells (WBC) (Automated Hematology Analyzer XN series XN-20, sysmex) measured by flow cytometry were 31.11 mg/L and 10.2 × 109/L, respectively. The patient’s blood pressure was 164/101 mm Hg. Ceftazidime and cefazolin sodium pentahydrate were introduced by antibiotic therapy. The patient recovered and was discharged.
On 8 October 2018, a 53-year-old male patient as host of BS27 was admitted to the same hospital (as was the host of BS26) because of the acute onset of fever (body temperature of 38.9 °C), chill, cough, expectoration, and persistent pain in the right knee joint. His previous health status was well. The patient had been exposed to pigs one week prior to the onset of illness. A CT scan image indicated inflammation of both lungs. The serum level of hsCRP (cobas c 702, Roche) measured by nephelometry and total counts of WBC (Automated Hematology Analyzer XN series XN-20, sysmex) measured by flow cytometry were 54.84 mg/L and 22 × 109/L, respectively. Cefatriaxone was introduced for two weeks. The patient recovered.
4.2. DNA Extraction, Sequencing, and Bioinformatic Analysis
The strains were grown overnight on Columbia blood base agar (Thermo Fisher Scientific, Beijing, China) at 37 °C with 5% CO2. The genomic DNA of two strains was extracted and purified with the Wizard Genomic DNA Purification kit (Promega, Madison, WI, USA). A complete genome of BS26 was sequenced using PacBio Sequel platform and Illumina NovaSeq PE150. A draft genome of BS27 was sequenced using Illumina NovaSeq PE150. PacBio Sequel platform Libraries for single-molecule real-time (SMRT) sequencing was constructed with an insert size of 10 kb using the SMRT bell TM Template kit, version 1.0. In summary, the process was to fragment and concentrate DNA, repair DNA damage and ends, prepare blunt ligation reaction, purify SMRTbell Templates with 0.45X AMPure PB Beads, select size by using the BluePippin System, and repair DNA damage after size selection. Last, the library quality was assessed on the Qubit® 2.0 Fluorometer (Thermo Fisher Scientific, Waltham, MA, USA), and the insert-fragment size was detected by Agilent 2100 (Agilent Technologies, Santa Clara, CA, USA). Sequencing libraries of Illumina NovaSeq platform were generated using NEBNext® Ultra™ DNA Library Prep Kit for Illumina (NEB, Ipswich, England), by following the manufacturer’s recommendations; and index codes were added to attribute sequences to each sample. Briefly, the DNA sample was fragmented by sonication to a size of 350 bp, and then DNA fragments were end-polished, A-tailed, and ligated with the full-length adaptor for Illumina sequencing with further PCR amplification. Last, PCR products were purified using AMPure XP system (Beckman Coulter, Brea, CA, USA), and libraries were analyzed for size distribution by Agilent2100 (Agilent Technologies) and quantified using real-time PCR. The generated reads were assembled using SOAPdenovo (release 1.04). Genes were predicted by using Glimmer 3.02, and gene orthologs were determined by using OrthoMCL V1.4. The complete genome of strain BS26 (1,932,292 bp) contained 2022 genes and had a G+C content of 39.75%. The draft genome of strain BS27 (1,909,795 bp) contained 2002 genes and had a G+C content of 39.69%. The coverage/depth of BS26 and BS27 genomes were 100%/288 and 98.84%/301, respectively. For comparison, 11 draft genomes of S. parasuis strains were also added, including serotype 20 reference strain 86-5192, serotype 22 reference strain 88-1861, serotype 26 reference strain 89-4109-1, SUT-7, SUT-286, SUT-319, SUT-328, SUT-380, 2674, 4253 [35], and 10-36905 (Table 1).
4.3. Phylogenetic Analysis of 16S RNA and Housekeeping Genes
Full-length 16S rRNA, housekeeping genes groEL, gyrB, sodA, and recN sequences of the S. parasuis were retrieved from the GenBank database or assembled genomes and aligned by the program CLUSTAL W. With the MEGA 7 software (available online: www.megasoftware.net, accessed on 27 February 2021), the 16S rRNA and housekeeping genes’ sequence-based phylogenetic trees were constructed with neighbor-joining algorithms. The stability of the groupings was estimated by bootstrap analysis at the level of 1000 replications, and the genetic distances were calculated by the Kimura 2-parameter method. The corresponding sequences of S. suis type strain NCTC10234T (Accession no. PRJEB6403) were included. The corresponding sequences of Enterococcus faecalis JCM 5803 (Accession no. NR_040789.1) or S. suis type strain NCTC10234T were used as out-group to root the trees.
4.4. Experimental Infection
4.4.1. Survival Assay
For comparison, a highly pathogenic S. suis strain P1/7 that was isolated from a pig with meningitis [11] was included in the present study. C57BL/6 mice (6 weeks old, female) were injected intraperitoneally with 5 × 107 CFU of the live S. parasuis strain BS26, S. parasuis strain BS27, and S. suis strain P1/7 in 1 mL PBS or 1 mL PBS only as control group. Each strain-infected group contained ten mice and the mock-infected group contained five mice. The mortality was recorded per two hours within 12 h post-infection and per six hours from 12 h to 72 h post-infection. The experiment was performed independently in duplicate. Overall survival rates of the two experiments for each infected group were calculated via the Kaplan–Meier method.
4.4.2. Histopathological Analysis and Bacterial Loads in Survival Mice
In survival assay, the peripheral blood, brain, lung, liver, spleen, and kidney of all survival mice at 72 h post-infection (three mice infected with S. parasuis strain BS26, five mice infected with S. parasuis strain BS27 and three mice infected with S. suis strain P1/7) were collected aseptically.
One hundred microliters of serial tenfold dilutions of peripheral blood of each infected mouse were plated onto blood agar plates. Part of organs were accurately weighted and thoroughly ground to homogenate, placed in 1 mL of PBS. One hundred microliters of serial tenfold dilutions of organ homogenate were plated onto blood agar plates. Colonies were expressed as CFU/0.1 g for organ samples or CFU/mL for blood samples. The median values were used to express the bacterial counts of each group.
Another part of organs was fixed for 24 h at room temperature in 4% buffered formalin. After paraffin embedding, tissue sections conventional dewaxing to water were stained with H&E and dehydrated according to standard protocol. The images were acquired and analyzed under light microscopy.
4.4.3. In Vivo Cytokine Production and Measurement of Bacterial Loads
C57BL/6 mice (6 weeks old, female) were injected intraperitoneally with 1 × 107 CFU of the live S. parasuis strain BS26 and S. suis strain P1/7 strains in 1 mL PBS. Each group contained five mice. At 4 h, 8 h, 12 h, 16 h, and 24 h post-infection, the mice were killed, and the peripheral blood of each infected mouse was collected aseptically. These experiments were performed twice. All serum samples were tested with concentrations of IL-6 and TNF-α using the ELISA kit (R&D Systems, Minneapolis, MN, USA), as recommended by the manufacturer. The cytokine values were expressed as the median pg/mL values. The bacterial counts in peripheral blood, liver, lung, and brain of infected mice were measured according to the methods described in 4.4.2. The median values were used to express the bacterial counts of each group.
4.5. Detection of Antibiotic Resistance (AR) Determinants and Antimicrobial Susceptibility Profiles
We analyzed AR genes by searching the Comprehensive Antibiotic Resistance database (CARD) and the Antibiotic Resistance genes database (ARDB). We regarded a resistance gene as a homolog in the tested strains only if it exhibited at least 80% identity in the protein’s sequence across 80% of the protein’s length [36]. We tested for antimicrobial susceptibility by assessing the minimum inhibitory concentration (MIC) for all isolates by using an MIC-test strip (Liofilchem, Roseto degli Abruzzi, Italy). Those strips had a range of concentrations of penicillin G (0.002–32 μg/mL), cefaclor (0.016–256 μg/mL), tetracycline (0.016–256 μg/mL), erythromycin (0.016–256 μg/mL), azithromycin (0.016–256 μg/mL), clindamycin (0.016–256 μg/mL), chloramphenicol (0.016–256 μg/mL), vancomycin (0.016–256 μg/mL), streptomycin (0.064–1024 μg/mL), kanamycin (0.016–256 μg/mL), spectinomycin (0.064–1024 μg/mL), gentamicin (0.016–256 μg/mL), and trimethoprim-sulfamethoxazole (0.002–32 μg/mL). For quality control, we used S. pneumoniae ATCC 49619. For penicillin G, tetracycline, azithromycin, erythromycin, clindamycin, vancomycin, and chloramphenicol, breakpoints were used as recommended by the Clinical and Laboratory Standard Institute (CLSI) guidelines 2019 (M100-S29) for Streptococcus spp. Viridans group. For cefaclor and trimethoprim-sulfamethoxazole, breakpoints were used as recommended by the Clinical and Laboratory Standard Institute (CLSI) guidelines 2019 (M100-S29) for S. pneumoniae. No breakpoint values of streptomycin, kanamycin, gentamicin, and spectinomycin were available for Streptococcus. Their breakpoints were taken from previous studies of S. suis [37,38]. Breakpoints of antimicrobial agents are as follows: penicillin G, >4 μg/mL; cefaclor, >4 μg/mL; tetracycline, >8 μg/mL; azithromycin, >2 μg/mL; erythromycin, >1 μg/mL; clindamycin, >1 μg/mL; chloramphenicol, >16 μg/mL; vancomycin, >2 μg/mL; trimethoprim-sulfamethoxazole, >4 μg/mL; streptomycin, >250 μg/mL; kanamycin, >250 μg/mL; gentamicin, >250 μg/mL, and spectinomycin, >250 μg/mL.
4.6. Comparative Genomic Analysis of S. parasuis
Thirteen S. parasuis genomes and genome of S. suis type strain NCTC10234T were included in the comparative genomic analysis. The average nucleotide identity (ANI) analysis was performed on the OrthoANIu platform (available online: https://www.ezbiocloud.net/tools/orthoaniu, accessed on 20 November 2020) to define species boundaries of bacteria [39].
The whole genome phylogenetic tree based on 442 core genes of 14 genomes was constructed by Roary [40]. The core genes were extracted by BLASTP (96% identity, 99% of isolates a gene must be in to be core). The sequences of core genome were concatenated and aligned by MAFFT multiple sequence alignment program. The phylogenetic tree based on core genome was constructed by using the maximum likelihood algorithms in FastTree. The S. suis type strain NCTC10234T was used as out-group to root the tree.
4.7. Analysis of cps Loci
Each cps locus sequence was extracted from the genomes. The TMHMM v2.0 analysis program (available online: http://www.cbs.dtu.dk/services/TMHMM/, accessed on 15 October 2020) was used to identify putative transmembrane proteins WZX and WZY. The wzy genes having a global match region at <50% of the amino-acid sequence and with an identity of <50% were identified as different cps types in pairwise comparisons between S. parasuis genomes. The sequence comparison was performed using blastN program in BLAST with an e-value cutoff of e-10 and was visualized using an in-house Perl script (available online: https://github.com/dupengcheng/BlastViewer, accessed on 2 March 2021).
4.8. Statistics
The survival rates of different groups were compared using Log-rank test. Significant difference in bacterial counts between S. suis and S. parasuis-infected group was determined by Wilcoxon’s two-sample test. Statistical analysis of the cytokine data was performed by using the Wilcoxon’s two-sample test. For these tests, a p-value < 0.05 was considered to be significant.
4.9. Nucleotide Sequence Accession Numbers
The sequences of the 2 S. parasuis strains that were sequenced in the study were deposited in the GenBank under accession numbers CP069079 (BS26) and JAETXU000000000 (BS27).
Supplementary Materials
The following are available online at https://www.mdpi.com/article/10.3390/pathogens10070834/s1. Table S1. Sequence similarity of 16S rRNA gene and housekeeping genes and ANI values among genomes that the present study used. Table S2. Survival table of each infected group and statistical data in survival assay.
Author Contributions
Conceptualization, H.Z.; methodology, H.Z., J.W., P.L., and Y.W.; validation, D.J. and J.Y.; formal analysis, Y.T., Y.W., D.J., and J.Y.; investigation, X.Y. and B.L.; resources, X.Y. and B.L.; data curation, H.Z.; writing—original draft preparation, J.W. and P.L.; writing—review and editing, H.Z.; supervision, H.Z.; funding acquisition, H.Z. All authors have read and agreed to the published version of the manuscript.
Funding
This work was supported by the Priority Project on Infectious Disease Control and Prevention from the Ministry of Science and Technology of the People’s Republic of China [Grant No. 2017ZX10303405-002, 2018ZX10734404] and the National Natural Science Foundation of China [Grant No. 81572044].
Institutional Review Board Statement
The study was approved by the ethics committee of the National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention (protocol code 2020-021 and 29-12-2020 of approval).
Informed Consent Statement
Informed consent was obtained from all patients to collect clinical strains and related information used in the study.
Data Availability Statement
The data presented in this study are openly available in the article and its Supplementary Material.
Conflicts of Interest
The authors declare no conflict of interest.
Footnotes
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Goyette-Desjardins G., Auger J.P., Xu J., Segura M., Gottschalk M. Streptococcus suis, an important pig pathogen and emerging zoonotic agent-an update on the worldwide distribution based on serotyping and sequence typing. Emerg. Microbes Infect. 2014;3:e45. doi: 10.1038/emi.2014.45. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Gajdács M., Németh A., Knausz M., Barrak I., Stájer A., Mestyán G., Melegh S., Nyul A., Tóth Á., Ágoston Z., et al. Streptococcus suis: An Underestimated Emerging Pathogen in Hungary? Microorganisms. 2020;8:1292. doi: 10.3390/microorganisms8091292. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Ágoston Z., Terhes G., Hannauer P., Gajdács M., Urbán E. Fatal case of bacteremia caused by Streptococcus suis in a splenectomized man and a review of the European literature. Acta Microbiol. Immunol. Hung. 2020;67:148–155. doi: 10.1556/030.2020.01123. [DOI] [PubMed] [Google Scholar]
- 4.Hill J.E., Gottschalk M., Brousseau R., Harel J., Hemmingsen S.M., Goh S.H. Biochemical analysis, cpn60 and 16S rDNA sequence data indicate that Streptococcus suis serotypes 32 and 34, isolated from pigs, are Streptococcus orisratti. Vet. Microbiol. 2005;107:63–69. doi: 10.1016/j.vetmic.2005.01.003. [DOI] [PubMed] [Google Scholar]
- 5.Nomoto R., Maruyama F., Ishida S., Tohya M., Sekizaki T., Osawa R. Reappraisal of the taxonomy of Streptococcus suis serotypes 20, 22 and 26: Streptococcus parasuis sp. nov. Int. J. Syst. Evol. Microbiol. 2015;65:438–443. doi: 10.1099/ijs.0.067116-0. [DOI] [PubMed] [Google Scholar]
- 6.Yamada R., Tien L.H.T., Arai S., Tohya M., Ishida-Kuroki K., Nomoto R., Kim H., Suzuki E., Osawa R., Watanabe T., et al. Development of PCR for identifying Streptococcus parasuis, a close relative of Streptococcus suis. J. Vet. Med. Sci. 2018;80:1101–1107. doi: 10.1292/jvms.18-0083. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Gottschalk M., Lacouture S. Canada: Distribution of Streptococcus suis (from 2012 to 2014) and Actinobacillus pleuropneumoniae (from 2011 to 2014) serotypes isolated from diseased pigs. Can. Vet. J. 2015;56:1093–1094. [PMC free article] [PubMed] [Google Scholar]
- 8.Gottschalk M., Lacouture S., Bonifait L., Roy D., Fittipaldi N., Grenier D. Characterization of Streptococcus suis isolates recovered between 2008 and 2011 from diseased pigs in Québec, Canada. Vet. Microbiol. 2013;162:819–825. doi: 10.1016/j.vetmic.2012.10.028. [DOI] [PubMed] [Google Scholar]
- 9.Wei Z., Li R., Zhang A., He H., Hua Y., Xia J., Cai X., Chen H., Jin M. Characterization of Streptococcus suis isolates from the diseased pigs in China between 2003 and 2007. Vet. Microbiol. 2009;137:196–201. doi: 10.1016/j.vetmic.2008.12.015. [DOI] [PubMed] [Google Scholar]
- 10.Gottschalk M., Higgins R., Jacques M., Beaudoin M., Henrichsen J. Characterization of six new capsular types (23 through 28) of Streptococcus suis. J. Clin. Microbiol. 1991;29:2590–2594. doi: 10.1128/jcm.29.11.2590-2594.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Holden M.T.G., Hauser H., Sanders M., Ngo T.H., Cherevach I., Cronin A., Goodhead I., Mungall K., Quail M.A., Price C., et al. Rapid Evolution of Virulence and Drug Resistance in the Emerging Zoonotic Pathogen Streptococcus suis. PLoS ONE. 2009;4:e6072. doi: 10.1371/journal.pone.0006072. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Okura M., Osaki M., Nomoto R., Arai S., Osawa R., Sekizaki T., Takamatsu D. Current Taxonomical Situation of Streptococcus suis. Pathogens. 2016;5:45. doi: 10.3390/pathogens5030045. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Niu L., Lu S., Hu S., Jin D., Lai X., Yang J., Chen C., Wang Y., Wang Y., Bai X., et al. Streptococcus marmotae sp. nov., isolated from the respiratory tract of Marmota himalayana. Int. J. Syst. Evol. Microbiol. 2016;66:4315–4322. doi: 10.1099/ijsem.0.001350. [DOI] [PubMed] [Google Scholar]
- 14.Du H., Huang W., Xie H., Ye C., Jing H., Ren Z., Xu J. The genetically modified suilysin, rSLYP353L, provides a candidate vaccine that suppresses proinflammatory response and reduces fatality following infection with Streptococcus suis. Vaccine. 2013;31:4209–4215. doi: 10.1016/j.vaccine.2013.07.004. [DOI] [PubMed] [Google Scholar]
- 15.Domínguez-Punaro M.C., Segura M., Plante M.-M., Lacouture S., Rivest S., Gottschalk M. Streptococcus suis Serotype 2, an Important Swine and Human Pathogen, Induces Strong Systemic and Cerebral Inflammatory Responses in a Mouse Model of Infection. J. Immunol. 2007;179:1842–1854. doi: 10.4049/jimmunol.179.3.1842. [DOI] [PubMed] [Google Scholar]
- 16.Lachance C., Gottschalk M., Gerber P.P., Lemire P., Xu J., Segura M. Exacerbated Type II Interferon Response Drives Hypervirulence and Toxic Shock by an Emergent Epidemic Strain of Streptococcus suis. Infect. Immun. 2013;81:1928–1939. doi: 10.1128/IAI.01317-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Okura M., Takamatsu D., Maruyama F., Nozawa T., Nakagawa I., Osaki M., Sekizaki T., Gottschalk M., Kumagai Y., Hamada S. Genetic Analysis of Capsular Polysaccharide Synthesis Gene Clusters from All Serotypes of Streptococcus suis: Potential Mechanisms for Generation of Capsular Variation. Appl. Environ. Microbiol. 2013;79:2796–2806. doi: 10.1128/AEM.03742-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Yarza P., Richter M., Peplies J., Euzeby J., Amann R., Schleifer K.-H., Ludwig W., Glöckner F.O., Rosselló-Móra R. The All-Species Living Tree project: A 16S rRNA-based phylogenetic tree of all sequenced type strains. Syst. Appl. Microbiol. 2008;31:241–250. doi: 10.1016/j.syapm.2008.07.001. [DOI] [PubMed] [Google Scholar]
- 19.Zhang W., Du P., Zheng H., Yu W., Wan L., Chen C. Whole-genome sequence comparison as a method for improving bacterial species definition. J. Gen. Appl. Microbiol. 2014;60:75–78. doi: 10.2323/jgam.60.75. [DOI] [PubMed] [Google Scholar]
- 20.Goris J., Konstantinidis K.T., Klappenbach J.A., Coenye T., Vandamme P., Tiedje J.M. DNA–DNA hybridization values and their relationship to whole-genome sequence similarities. Int. J. Syst. Evol. Microbiol. 2007;57:81–91. doi: 10.1099/ijs.0.64483-0. [DOI] [PubMed] [Google Scholar]
- 21.Ye C., Zheng H., Zhang J., Jing H., Wang L., Xiong Y., Wang W., Zhou Z., Sun Q., Luo X., et al. Clinical, Experimental, and Genomic Differences between Intermediately Pathogenic, Highly Pathogenic, and EpidemicStreptococcus suis. J. Infect. Dis. 2009;199:97–107. doi: 10.1086/594370. [DOI] [PubMed] [Google Scholar]
- 22.Dofferhoff A.S., Vellenga E., Limburg P.C., Van Zanten A., Mulder P.O., Weits J. Tumour necrosis factor (cachectin) and other cytokines in septic shock: A review of the literature. Neth. J. Med. 1991;39:45–62. [PubMed] [Google Scholar]
- 23.Norrby-Teglund A., Pauksens K., Norgren M., Holm S.E. Correlation between Serum TNFα and IL6 levels and Severity of Group: A Streptococcal Infections. Scand. J. Infect. Dis. 1995;27:125–130. doi: 10.3109/00365549509018991. [DOI] [PubMed] [Google Scholar]
- 24.Faulkner L., Cooper A., Fantino C., Altmann D., Sriskandan S. The Mechanism of Superantigen-Mediated Toxic Shock: Not a Simple Th1 Cytokine Storm. J. Immunol. 2005;175:6870–6877. doi: 10.4049/jimmunol.175.10.6870. [DOI] [PubMed] [Google Scholar]
- 25.Zheng H., Ye C., Segura M., Gottschalk M., Xu J. Mitogenic effect contributes to increased virulence of Streptococcus suis sequence type 7 to cause streptococcal toxic shock-like syndrome. Clin. Exp. Immunol. 2008;153:385–391. doi: 10.1111/j.1365-2249.2008.03722.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Wang M., Du P., Wang J., Lan R., Huang J., Luo M., Jiang Y., Zeng J., Quan Y., Shi Z., et al. Genomic Epidemiology of Streptococcus suis Sequence Type 7 Sporadic Infections in the Guangxi Zhuang Autonomous Region of China. Pathogens. 2019;8:187. doi: 10.3390/pathogens8040187. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Palmieri C.P., Varaldo P.E.M., Facinelli B.P. Streptococcus suis, an Emerging Drug-Resistant Animal and Human Pathogen. Front. Microbiol. 2011;2:235. doi: 10.3389/fmicb.2011.00235. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Huang J., Ma J., Shang K., Hu X., Liang Y., Li D., Wu Z., Dai L., Chen L., Wang L. Evolution and Diversity of the Antimicrobial Resistance Associated Mobilome in Streptococcus suis: A Probable Mobile Genetic Elements Reservoir for Other Streptococci. Front. Cell. Infect. Microbiol. 2016;6:118. doi: 10.3389/fcimb.2016.00118. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Yun K.W., Cho E.Y., Choi E.H., Lee H.J. Capsular polysaccharide gene diversity of pneumococcal serotypes 6A, 6B, 6C, and 6D. Int. J. Med Microbiol. 2014;304:1109–1117. doi: 10.1016/j.ijmm.2014.08.004. [DOI] [PubMed] [Google Scholar]
- 30.Liu Z., Zheng H., Gottschalk M., Bai X., Lan R., Ji S., Liu H., Xu J. Development of Multiplex PCR Assays for the Identification of the 33 Serotypes of Streptococcus suis. PLoS ONE. 2013;8:e72070. doi: 10.1371/journal.pone.0072070. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Baker G., Smith J., Cowan D. Review and re-analysis of domain-specific 16S primers. J. Microbiol. Methods. 2003;55:541–555. doi: 10.1016/j.mimet.2003.08.009. [DOI] [PubMed] [Google Scholar]
- 32.Okwumabua O., O’Connor M., Shull E. A polymerase chain reaction (PCR) assay specific forStreptococcus suisbased on the gene encoding the glutamate dehydrogenase. FEMS Microbiol. Lett. 2003;218:79–84. doi: 10.1111/j.1574-6968.2003.tb11501.x. [DOI] [PubMed] [Google Scholar]
- 33.Tien L.H.T., Nishibori T., Nishitani Y., Nomoto R., Osawa R. Reappraisal of the taxonomy of Streptococcus suis serotypes 20, 22, 26, and 33 based on DNA–DNA homology and sodA and recN phylogenies. Vet. Microbiol. 2013;162:842–849. doi: 10.1016/j.vetmic.2012.11.001. [DOI] [PubMed] [Google Scholar]
- 34.Ishida S., Tien L.H.T., Osawa R., Tohya M., Nomoto R., Kawamura Y., Takahashi T., Kikuchi N., Kikuchi K., Sekizaki T. Development of an appropriate PCR system for the reclassification of Streptococcus suis. J. Microbiol. Methods. 2014;107:66–70. doi: 10.1016/j.mimet.2014.09.003. [DOI] [PubMed] [Google Scholar]
- 35.Stevens M.J.A., Cernela N., Corti S., Stephan R. Draft Genome Sequence of Streptococcus parasuis 4253, the First Available for the Species. Microbiol. Resour. Announc. 2019;8:e00203-19. doi: 10.1128/MRA.00203-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Hu Y., Yang X., Qin J., Lu N., Cheng G., Wu N., Pan Y., Li J., Zhu L., Wang X., et al. Metagenome-wide analysis of antibiotic resistance genes in a large cohort of human gut microbiota. Nat. Commun. 2013;4:2151. doi: 10.1038/ncomms3151. [DOI] [PubMed] [Google Scholar]
- 37.Huang K., Zhang Q., Song Y., Zhang Z., Zhang A., Xiao J., Jin M. Characterization of Spectinomycin Resistance in Streptococcus suis Leads to Two Novel Insights into Drug Resistance Formation and Dissemination Mechanism. Antimicrob. Agents Chemother. 2016;60:6390–6392. doi: 10.1128/AAC.01157-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Marie J., Morvan H., Berthelot-Hérault F., Sanders P., Kempf I., Gautier-Bouchardon A.V., Jouy E., Kobisch M. Antimicrobial susceptibility of Streptococcus suis isolated from swine in France and from humans in different countries between 1996 and 2000. J. Antimicrob. Chemother. 2002;50:201–209. doi: 10.1093/jac/dkf099. [DOI] [PubMed] [Google Scholar]
- 39.Yoon S.-H., Ha S.-M., Lim J., Kwon S., Chun J. A large-scale evaluation of algorithms to calculate average nucleotide identity. Antonie van Leeuwenhoek. 2017;110:1281–1286. doi: 10.1007/s10482-017-0844-4. [DOI] [PubMed] [Google Scholar]
- 40.Page A.J., Cummins C.A., Hunt M., Wong V.K., Reuter S., Holden M.T.G., Fookes M., Falush D., Keane J.A., Parkhill J. Roary: Rapid large-scale prokaryote pan genome analysis. Bioinformatics. 2015;31:3691–3693. doi: 10.1093/bioinformatics/btv421. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The data presented in this study are openly available in the article and its Supplementary Material.